Total Payments
$70,544
2024 Payments
$18,056
Companies
24
Transactions
277
Medicare Patients
624
Medicare Billing
$138,367
Payment Breakdown by Category
Other$60,124 (85.2%)
Food & Beverage$6,426 (9.1%)
Consulting$2,943 (4.2%)
Travel$1,037 (1.5%)
Education$13.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,444 | 35 | 82.8% |
| Food and Beverage | $6,426 | 225 | 9.1% |
| Consulting Fee | $2,943 | 4 | 4.2% |
| Honoraria | $1,680 | 1 | 2.4% |
| Travel and Lodging | $1,037 | 10 | 1.5% |
| Education | $13.92 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $35,006 | 117 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $12,606 | 24 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $10,838 | 14 | $0 (2022) |
| Lilly USA, LLC | $5,843 | 18 | $0 (2023) |
| Allergan, Inc. | $2,168 | 28 | $0 (2022) |
| Lundbeck LLC | $1,971 | 12 | $0 (2024) |
| Amgen Inc. | $551.52 | 9 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $274.97 | 12 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $269.02 | 15 | $0 (2024) |
| PFIZER INC. | $258.03 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,056 | 52 | ABBVIE INC. ($16,107) |
| 2023 | $14,274 | 51 | ABBVIE INC. ($13,747) |
| 2022 | $13,164 | 65 | Biohaven Pharmaceutical Holding Company Ltd. ($10,838) |
| 2021 | $22,102 | 54 | Biohaven Pharmaceuticals, Inc. ($11,316) |
| 2020 | $1,723 | 21 | Biohaven Pharmaceuticals, Inc. ($1,290) |
| 2019 | $1,052 | 30 | Supernus Pharmaceuticals, Inc. ($186.10) |
| 2018 | $48.40 | 3 | Allergan Inc. ($20.33) |
| 2017 | $125.00 | 1 | Amgen Inc. ($125.00) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $1,680.00 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Neurology | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 09/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $143.00 | General |
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $120.57 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 171 | 239 | $79,545 | $22,104 |
| 2022 | 6 | 169 | 5,008 | $126,897 | $48,133 |
| 2021 | 6 | 198 | 6,277 | $152,387 | $57,671 |
| 2020 | 4 | 86 | 105 | $30,454 | $10,459 |
Total Patients
624
Total Services
11,629
Medicare Billing
$138,367
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 125 | $36,094 | $10,302 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $19,940 | $5,314 | 26.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 12 | 28 | $12,520 | $3,163 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $6,216 | $1,901 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 25 | $4,775 | $1,425 | 29.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 4,800 | $61,152 | $23,511 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 98 | $26,950 | $10,992 | 40.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $16,036 | $5,444 | 33.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 12 | 25 | $10,647 | $3,371 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 18 | $6,660 | $2,779 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 29 | $5,452 | $2,036 | 37.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 13 | 6,045 | $77,013 | $29,349 | 38.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 90 | $24,645 | $10,595 | 43.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $24,059 | $7,490 | 31.1% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 13 | 30 | $12,652 | $4,221 | 33.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 21 | $7,762 | $3,373 | 43.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 33 | $6,256 | $2,644 | 42.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $10,908 | $3,809 | 34.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 40 | $10,520 | $3,573 | 34.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $4,576 | $1,769 | 38.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 25 | $4,450 | $1,309 | 29.4% |
About Dr. Laura Cinski, M.D
Dr. Laura Cinski, M.D is a Neurology healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003006198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Cinski, M.D has received a total of $70,544 in payments from pharmaceutical and medical device companies, with $18,056 received in 2024. These payments were reported across 277 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,444).
As a Medicare-enrolled provider, Cinski has provided services to 624 Medicare beneficiaries, totaling 11,629 services with total Medicare billing of $138,367. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Fairfax, VA
- Active Since 07/26/2007
- Last Updated 02/06/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003006198
Products in Payments
- QULIPTA (Drug) $23,720
- NURTEC ODT (Drug) $23,702
- UBRELVY (Drug) $10,565
- REYVOW (Drug) $3,563
- EMGALITY (Drug) $2,158
- VYEPTI (Biological) $1,971
- BOTOX (Biological) $742.46
- Aimovig (Biological) $426.52
- TROKENDI XR (Drug) $232.84
- APTIOM (Drug) $225.76
- NUEDEXTA (Drug) $124.99
- MAYZENT (Drug) $118.19
- KESIMPTA (Drug) $117.49
- SOLIRIS (Drug) $115.92
- Briviact (Drug) $52.12
- OXTELLAR XR (Drug) $42.13
- Trudhesa (Drug) $37.18
- INBRIJA (Drug) $36.42
- GILENYA (Drug) $33.34
- DUOPA (Drug) $32.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fairfax
Dr. Rahul Dave, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $405,192
Neurology $405,192
John Rothrock, Md, MD
Neurology — Payments: $347,072
Neurology $347,072
Abigail Lawler, M.d, M.D
Neurology — Payments: $45,925
Neurology $45,925
Dr. David Whitney, M.d, M.D
Neurology — Payments: $35,830
Neurology $35,830
Dr. Amy Safadi, Md, MD
Neurology — Payments: $22,090
Neurology $22,090
Hannah Irving, Md, MD
Neurology — Payments: $6,570
Neurology $6,570